Screener
Eligibility screening
A Phase II Trial of Loncastuximab Tesirine for Relapsed/Refractory Large B-cell Lymphoma After CAR T-cell Therapy
1 US site in TX
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.